13F filing recap · Q1 2016
What did ArrowMark Partners buy in Q1 2016?
Reported stock-position changes between this filing and the previous one. US-listed stocks across every ArrowMark account, including accounts that belong to no fund below.
Stock value
$4.50B
Positions
259
Estimated turnover
38.4%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
DXCMDexcom, Inc.$32.07Mreported value+472.2K sharesABMDAbiomed Inc$31.82Mreported value+335.6K sharesSLCAU.s. Silica Holdings, Inc.$26.89Mreported value+1.18M sharesNVRONevro Corp$22.60Mreported value+401.7K sharesNEWRNew Relic Inc$21.68Mreported value+831.3K sharesABCOThe Advisory Board Company$21.63Mreported value+670.6K sharesENSEnersys$6.13Mreported value+110.0K sharesSRUNUSilver Run Acquisition Corporation II$4.20Mreported value+405.5K sharesENVEnvestnet, Inc.$3.45Mreported value+126.9K sharesOIO-I Glass, Inc.$2.79Mreported value+174.9K sharesQTWOQ2 Holdings, Inc.$2.73Mreported value+113.6K sharesSCORComscore, Inc.$2.46Mreported value+81.9K sharesAXONAxon Enterprise, Inc.$2.46Mreported value+125.2K sharesHSTMHealthstream, Inc.$2.39Mreported value+108.0K sharesSNDXSyndax Pharmaceuticals Inc$2.00Mreported value+149.9K sharesMMSIMerit Medical Systems Inc$1.71Mreported value+92.6K sharesONCBeone Medicines Ltd.$1.38Mreported value+47.0K sharesTIFTiffany & Co.$812.0Kreported value+11.1K sharesMAMastercard Inc$561.0Kreported value+5.9K sharesTAT&T Inc.$213.0Kreported value+5.4K shares